Coronavirus has kept drug developers and researchers on their toes since March as the world is suffering from the pandemic. While researchers have been trying to figure out the best treatment options, a small study conducted in France suggested that popular anti-malaria drugs hydroxychloroquine and chloroquine could help in dealing with the virus.
However, medical experts all over the world have been questioning this study and have repeatedly asked for more research on impact of hydroxychloroquine and chloroquine.
President Donald Trump touted the drugs as game changer and even threatened India with tariffs if the country doesn't lift the ban on export of hydroxychloroquine and chloroquine. India agreed to send the pills to United States but it is still not sure if the pills are effective against COVID-19.
A new research conducted in France has suggested that hydroxychloroquine and chloroquine aren't effective in treatment of coronavirus.
An article published by antiviral researcher Katherine Seley-Radtke Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County.
The Seley-Radtke research group is focused on the discovery, design and synthesis of nucleoside/nucleotide and heterocyclic enzyme inhibitors with chemotherapeutic emphasis in the areas of anticancer, antiviral, antibiotic, and antiparasitic targets.
After the current research, stockpiling of hydroxychloroquine and chloroquine should reduce but with President Trump's support for these pills, people will still keep on buying them. Even placebo works in many cases. So, people might feel that they are safe once they take a single pill of hydroxychloroquine or chloroquine per week. The pills don't have any major side effects if taken once in a week.